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Abstract 
Embryonic stem cells can be obtained by generating an embryo through fertilization; however, 
an embryo can also be generated asexually through parthenogenesis. This procedure will overcome the 
ethical issues regarding the use of embryos initially generated for reproductive purposes. The aim of this 
study was to obtain an optimized oocyte activation method through parthenogenesis by using mice oocytes 
as a model. Ten mM SrCl2 and 5 µg/ml Cytochalasin B (CB) in calcium-free Chatot Ziomek Bavister 
(CZB) were used as a medium for an in vitro activation of mouse oocytes. Treatment combinations for the 
oocyte activation methods were (A) activation in CZB & SrCl2 (prepared in stock) for two hours and in 
CZB & CB for four hours; (B) activation in CZB & SrCl2 (fresh medium) for two hours and in CZB & CB 
for four hours; and (C) activation in CZB & CB & SrCl2 (fresh medium) for six hours. The results show 
that the activation rate of  mouse oocytes  with  method C has  been  the best among all the protocols. This 
optimized protocol clearly provides a new insight in the generation of embryos for further use, particularly 
for producing embryonic stem cells. 
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Introduction 
An activation  method has 
commonly been used in manipulating 
embryos, especially for the production of 
parthenogenetic and cloned embryos.1,2 
Those embryos can be artificially 
activated to be developed into its 
blastocyst stage, from which the inner 
cell mass (ICM) can potentially be 
derived as a source of parthenogenetic 
embryonic stem cells (pESCs) and 
nuclear transfer embryonic stem cells 
(ntESCs).3,4 ESCs can be differentiated 
into specific cells for repairing human 
degenerative or damaged tissue.5 The 
application of mouse oocyte 
manipulation has potentially evolved as 
an experimental model because the use 
of human oocytes is ethically limited. 6 
Unfertilized mouse oocytes are 
ovulated from the ovarium at metaphase 
II (MII). This process is marked by an 
extrusion of the first polar body (PB I).7 
The cytostatic factor (CSF) affects the MII 
oocytes to stay stable until the 
fertilization.8 It is believed that the arrest 
of  the MII of the oocytes is caused by 
the high activity of Maturation 
Promoting Factor (MPF) and the CSF 
present in the cytoplasm.9 
An artificial activation of the MII 
oocytes is a modification of a natural 
fertilization. During the fertilization, the 
binding of the sperm by the oocyte 
plasma membrane induces the 
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intracellular Ca2+ release into the 
oocyte.10 There are several ways to 
activate oocytes for the parthenogenetic 
activation purpose. The artificial oocyte 
activation can be conducted through 
stimulating Ca2+ oscilation (increasing 
intracellular Ca2+ release) and inhibiting 
MPF & Mitogen Activating Factor kinase 
(MPFk) using cycloheximide & 
puromycin to prolong the periods of the 
incubation in the mouse oocytes. The use 
of Ca2+ stimulating substance is common 
in parthenogenesis and nuclear transfer 
studies.  
An activation method of the MII 
mouse oocytes can be conducted by 
electrical and chemical techniques. Some 
of the commonly employed agents for 
mouse oocyte activation are ethanol, 
Ca2+ ionophore, and SrCl2.11   Strontium 
chloride (SrCl2) has been successfully 
used to activate mouse oocytes after the 
nuclear transfer. Probably, strontium 
chloride induces multiple Ca2+ transients 
not only by displacing bound Ca2+ in the 
oocyte but also by inducing intracellular 
Ca2+ release. In order to prevent the 
second polar body (PB II) extrusion, 
Cytochalasin B should be added into the 
activation medium or culture medium 
after the activation treatment. In fact, 
Cytochalasin B has the capability to 
disrupt actin filaments and inhibit 
cytokinesis.12 
The activation rate of mouse 
oocytes can be affected by the type of the 
mouse strain, the quality of the oocytes, 
the type and concentration of the 
chemical reagents, the time of activation 
treatment, and the combination of the 
activation medium.11 This study 
investigated an optimal method of 
mouse oocyte activation by using a 
treatment combination of calcium-free 
CZB medium, SrCl2, and Cytochalasin B.  
 
 
Materials and Methods 
Superovulation  
A superovulation was 
stimulated by gonadotropin hormone as 
previously described.11 Briefly, mature 8-
10 weeks old Ddy female mice were 
induced to superovulate by an 
intraperitoneal (i.p.) injection of 5-7.5 IU 
Pregnant Mare’s Serum Gonadotrophin/ 
PMSG (Intervet International BV, 
Folligon, Boxmeer, Holland) and  46-48 h 
later by an i.p. injection of 5-7.5 IU 
human Chorionic Gonadotrophin/ hCG 
(Intervet International BV, Chorulon, 
Boxmeer, Holland).  
 
Oocytes Collection 
Oocytes collection was 
conducted through an observation using 
a stereo microscope (Nikon, SMZ-2T, 
Japan) as previously described.11 During 
the  period of 14-16 h after the hCG 
injection, the mice were humanly 
sacrificed by cervical dislocation. The 
body wall (peritoneum) was cut to open 
the abdominal cavity. The oviduct was 
pulled from the uterus and the ovary 
and transferred into a droplet of M2 
medium (Specialty medium, MR-015P-
D, Phillipsburg, New Jersey, USA) at a 
35mm petri dish (Nunc, 153066, 
Roskilde, Denmark). A 27 G×½” needle 
(Terumo, NN*2713R, Philippines) was 
used to slice a larger part of the oviduct 
transparently. Cumulus-oocytes 
complexes (COC) were turned out from 
the oviduct and transferred immediately 
into a droplet of M2 medium 
supplemented with 0.1% hyaluronidase 
(Sigma, H4272, St.Louis, MO, USA) to 
disperse the cumulus cells form the 
oocytes. Approximately ten minutes 
after the treatment using  hyaluronidase, 
the cumulus–free oocytes were 
transferred into a droplet of glucose-free 
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CZB medium supplemented with 1 
mg/ml Bovine Serum Albumin/ BSA 
(Sigma, A3311, St. Louis, MO, USA), 
covered with mineral oil (Sigma, M8410, 
St. Lois, MO, USA), and kept at 37°C 
under 5% CO2 in an incubator (Sanyo, 
MCO-95, Japan). Approximately 15 
minutes after the incubation, the oocyte 
morphology was observed to asses the 
quality of the oocytes. The parameters of 
good quality oocytes are ± 85 µm in 
diameter, homogeny cytoplasm (not 
fragmented cytoplasm), PB I extrusion, 
and normal distance between pellucid 
zone and cytoplasm. 
 
Vital Staining 
A vital staining was conducted 
to observe the viability of the oocytes.  
The oocytes were stained by using PBS 
(Gibco, 21600-010, Grand Island, NY, 
USA) medium supplemented with 10 
µg/ml Hoechst 33342 (Invitrogen, 
H1399, Eugene, USA) and 10 µg/ml 
Propidium Iodide (Sigma, P4170, St. 
Lois, MO, USA) for ten minutes. The 
results of the vital staining were 
observed on Terazaki/minitrays plate 
(Nunc, 163118, Roskilde, Denmark) 
under fluorescent microscope (Nikon, 
E600, Japan) with 380 nm of wave 
length. In this vital staining, the living 
oocytes were stained by Hoechst 33342 
(blue) and the dead oocytes were stained 
by Propidium Iodide (red). 
 
Oocytes Activation 
The oocytes activation was 
conducted in calcium-free CZB medium, 
10 mM SrCl2 (Sigma, 255521, St. Louis, 
MO, USA), 5 µg/ml Cytochalasin B 
(Sigma, C6762, St.Louis, MO, USA) as 
previously described but with 
modification.11,13,14 Only good qualities 
of mouse embryos were used for further 
treatment. Treatment combination for 
oocytes activation methods  were (A) 
activation in CZB & SrCl2 (prepared in 
stock) for two hours and in CZB & CB 
for four hours; (B) activation in CZB & 
SrCl2 (fresh medium) for two hours and 
in CZB & CB for four hours; (C) 
activation in CZB & CB & SrCl2 (fresh 
medium) for six hours. The present 
study (treatment A and B) compared  a 
different combination of calcium-free 
CZB medium and SrCl2 to determine the 
capability of SrCl2 prepared in a stock 
and in a fresh medium in the mouse 
oocytes activation in vitro. Treatment C 
is commonly used as an activation 
protocol in mouse oocytes after the 
nuclear transfer. Prolonged time 
exposure of CB is not affecting the 
activation process, but it is necessary to 
expose the activated oocytes to CB until 
the pro-nuclear formation is reached (six 
hours). This is the way to obtain diploid 
parthenogenetic embryos. 
 
In Vitro Culture and Determination of 
Activation Efficacy 
The in vitro culture of the 
activated oocytes was conducted as 
described previously (13). Briefly, 
following a serial washing in CZB 
medium, embryos were put in drops of 
glucose-free CZB medium supplemented 
with 1 mg/ml BSA. They were then kept 
at 37oC under atmosphere of 5% CO2 in 
air for 24 hours. Six hours after 
activation, the activated oocytes were 
observed under inverted oocytes to 
determine the presence of pronucleus, 
and were then returned to the incubator 
to assess further the in vitro 
development of the oocytes following 
the activation. 
 
Statistical Methods 
Completely Randomized Design 
(CRD) was used as experimental design 
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in the present study as previously 
described.15 The data were evaluated by 
one way analysis of variance (ANOVA), 
and the differences between the 
treatment groups were determined by a 
post hoc, Tukey-Honestly Significantly 
Different (HSD) test. The differences at a 
probability value (P) of 0.05 or less were 
considered to be significant. All of 
statistical analyses were conducted by 
using SPSS 15.0 for windows software. 
Results and Discussion 
In a natural ovulation, female 
mice could release 8 to 12 oocytes 
depending on the strain. A high number 
of oocytes were needed in the 
manipulation of the embryos, in which 
they were commonly produced through 
superovulation. The optimal PMSG and 
hCG dosages were varied in 2.5 to 10 IU 
depending on their strain.11 
The results (table 1.) showed 
that the highest mouse oocytes 
production was observed on a 
superovulation with a 7.5 IU dosage of 
PMSG and hCG (17.29 oocyte/mouse) 
and it was significantly different 
(P≤0.05) from that with a 5 IU dosage of 
PMSG and hCG (12.79 oocyte/mouse). 
A superovulation with a 7.5 IU dosage of 
PMSG and hCG also increased the 
number of the bad quality oocytes 
(14.22%) and was significantly different 
(P≤0.05) from a 5 IU dosage of PMSG 
and hCG (9.22%). However, the results 
indicated that the average of good 
quality oocytes on superovulation with a 
7.5 IU dosage of PMSG and hCG was the 
highest (14.83 oocytes/mouse) and it 
was significantly different from that 
with a 5 IU dosage of PMSG and hCG 
(11.61 oocytes/mouse). 
Based on the results, it was 
evident that the significant improvement 
of ddy mouse oocyte production was 
caused by the superovulation with a 7.5 
IU dosage of PMSG and hCG. However, 
this treatment also affected the quality of 
the oocytes to be worse than the ones 
treated by a 5 IU dosage of PMSG and 
hCG. It was assumed that  the higher 
dosage would influence the hormonal 
balance system and the growth of 
follicles to become mature. They would 
also affect the metaphase I chromosome 
alligment and increase aneuploidy in 
mouse oocytes maturated in vitro.16 The 
previous study showed that a 
superovulation method could decrease 
embryonic development capability in 
vitro and in vivo.17 Moreover, the 
method could increase abnormal 
blastocsyts, slow fetus development, and 
aberrant DNA methylation of imprinted 
loci.18,19 
 
Table 1. Production of Mouse Oocytes by Superovulation 
Dosages of 
PMSG & 
HCG 
No. of 
Mouse 
Total 
Number 
of 
Oocytes 
Average 
(oocytes/ 
mouse) 
Quality of oocytes based on 
morphology observation (%) 
Good 
(oocytes/mouse) 
Bad 
(oocytes/mouse
) 
5 IU 28 358 12.79a 11.61 (90.78)a 1.18  (9.22)a 
7,5 IU 59 1020 17.29b 14.83 (85.78)b 2.46 (14.22)b 
Note: values within columns with different superscripts are significantly different (P≤0.05).
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Table 2. Activation Rate of Mouse Oocytes at Twenty Hours Post Activation 
Activation 
Methods 
No. of Oocytes 
Assessed 
Activation Rate (%) 
Not Cleveage Cleveage 
A 250 169 (67.60)a 81 (32.40)a 
B 146 36 (24.66)b 110 (75.34)b 
C 215 6 (2.79)c 209 (97.21)c 
Note: values within columns with different superscripts are significantly different (P≤0.05). 
Activation Methods:  
(A) Activation in CZB & SrCl2 (prepared in stock) for two hours and in CZB & CB for four hours;  
(B) Activation in CZB & SrCl2 (fresh medium) for two hours and in CZB & CB for four hours;  
(C) Activation in CZB & CB & SrCl2 (fresh medium) for six hours. 
 
 
In the present study (Tabel 2.), 
the activation rate of mouse oocytes with 
treatment C was the highest (97.21%) 
and significantly different (P≤0.05) from 
other treatments, i.e. treatment A 
(32.40%) and B (75.34%). Furthermore, 
the results indicated that treatment C 
with an activation in calcium-free CZB & 
CB & SrCl2 (fresh medium) for six hours 
was the optimal activation method for 
mouse oocytes in vitro. 
Calcium-free CZB medium was 
commonly used as the basic medium for  
oocyte activation.14,20 In an artificial 
activation, the extracellular calcium 
could influence the capability of SrCl2 to 
induce the oscillation of the intracellular 
ion calcium. The supplementation of 
SrCl2 into the medium was one of the 
methods to increase the ion Ca2+ signal 
oscillation in oocytes so that it would be 
capable to induce the biochemical 
reaction.8 It would trigger CSF 
degradation by ubiquitin or proteosome 
system. Ion Sr2+ could increase the ion 
Ca2+ oscillation of MII oocytes through 
InsP3 receptor.21 In order to inactivate 
MPF (the concentration would decrease), 
the inactive CSF would trigger the 
activation of APC and destroy cyclin A 
and cyclin B.22 The activated APC would 
induce the MII oocytes into anaphase.9 
In treatment C, it was assumed 
that six hours’ exposure of SrCl2 would 
be optimal to induce the ion  Ca2+ 
oscillation, whereas two hours’ exposure 
of  SrCl2 (treatment A & B) showed 
lower results of activation rate than 
treatment C. The activation rate of the 
mouse oocytes was influenced by using 
a medium stock (SrCl2 and calcium-free 
CZB prepared in a stock). It was 
assumed that the medium stock would 
decrease the capability of SrCl2 to induce 
the ion Ca2+ oscillation of the MII 
oocytes. In  treatment A, SrCl2 kept as a 
frozen solution had a lower activation 
rate than that prepared as a fresh 
solution. In order to reduce the time 
consumed for the activation protocols, 
the frozen stock of the activator agents 
has widely been used in parthenogenetic 
activation (Ca2+ionophore, Ionomycin, 
phorbol ester, and thimerosal) without 
significantly affecting the subsequent 
development in vitro of the activated 
oocytes. However, the factor(s) 
responsible of this discrepancy is 
unknown yet.23 
The confirmation of the oocytes’ 
viability showed that the good quality 
oocytes would markedly be in blue 
color, whereas the bad quality oocytes 
would markedly be in red color (figure 
1.D). In vital staining, Propidium Iodide 
 
 
JKM. Vol.8 No.2 Februari 2009: 113-120 
only penetrates into cytoplasm in the 
dead oocytes. After the activation 
treatment, the extrusion of PB II was 
successfully inhibited by adding  
Cytochalasin B, which generated diploid 
parthenogenetic embryos.12 This was 
evident in the formation of two 
pronucleus formation at six hours post 
activation (figure 1.E). At 20 hours post 
activation, the activated oocytes would 
develop into two cell stage oocytes 
(figure 1.F). 
 
          
118 
          
          
 
Figure 1. Morphology of Mouse Oocytes Prior to Superovulation, followed by Isolation 
and Activation. A. Cumulus-Oocytes Complexes (COC) after isolation from oviduct; B. 
Good quality oocytes based on a morphology observation ; C. Bad quality oocytes 
based on a morphology observation; D. Hoechst 33342-PI staining (blue = life, red = 
die); E. Formation of two pronucleus (2PN) at six hours post activation; F. Activated 
oocytes forming two-cell embryos at twenty hours post activation. Bar = 100 µm. 
 
A B 
C D 
E F 
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Conclusions and Suggestions 
Optimum results of in vitro 
activation of mouse oocytes can be 
achieved by a treatment combination of 
the activation in calcium-free CZB & CB 
& SrCl2 (fresh medium) for six hours. A 
superovulation method with a 7.5 IU 
dosage of both  PMSG and hCG was 
optimal for ddy female mouse. Clearly, 
by using the optimized protocol, 
parthenogenetic embryos were able to be 
generated more efficiently. The use of 
embryos to generate embryonic stem 
cells will assist further research for 
finding more treatments of diseases 
including a more rapid drug screening 
process. 
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